<DOC>
	<DOCNO>NCT02808065</DOCNO>
	<brief_summary>Pharmacokinetic model predict interaction tacrolimus mycophenolate develop clinical trial healthy volunteer . The purpose study confirm predictability develop pharmacokinetic model kidney transplant recipient .</brief_summary>
	<brief_title>Validation Population Pharmacokinetic Model Derived From Healthy Volunteer Kidney Transplant Recipients</brief_title>
	<detailed_description>Study participant take immunosuppressant usual . One day , blood drawn predose 1 , 2 , 3 , 4-hour postdose compare observe concentration model-predicted concentration tacrolimus mycophenolate .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Age 18 year old At least 6 month kidney transplantation Were tacrolimus alone tacrolimus plus mycophenolate base immunosuppressive regimen Maintained stable dose immunosuppressant least two week AST ALT &gt; 3 upper limit normal range Had gastrointestinal disorder may affect absorption drug Coadministration drug may affect pharmacokinetics immunosuppressive drug Multiorgan transplant recipient Severe psychiatric disorder Drug alcohol abuser Pregnant Low compliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Kidney transplant</keyword>
	<keyword>Kidney transplantation</keyword>
	<keyword>Renal transplant</keyword>
	<keyword>Renal transplantation</keyword>
</DOC>